Clinical Trials Browser

Phase 3 × INDUSTRY × Central Nervous System Neoplasms × Clear all

NCT07100730 2026-03-12

IPAX BrIGHT

Phase 3 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT00003293 2012-09-11

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Phase 3 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma